Chen, Y., Li, Q., Han, Y., Ji, H., Gu, M., Bian, R., . . . Mu, Y. (2019). Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study. Diabetes Ther.
Citación estilo ChicagoChen, Yulong, Quanmin Li, Ying Han, Hongmei Ji, Mingjun Gu, Rongwen Bian, Weiguang Ding, Jian Cheng, and Yiming Mu. "Vildagliptin Versus α-Glucosidase Inhibitor As Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study." Diabetes Ther 2019.
Cita MLAChen, Yulong, et al. "Vildagliptin Versus α-Glucosidase Inhibitor As Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study." Diabetes Ther 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.